Cargando…

Evaluation of (sdLDLc*HCYc)/HDLc ratio in clinical auxiliary diagnosis of primary cerebral infarction

BACKGROUND: Timely detection of cerebral infarction is of vital importance in planning intervention effect of rapid rehabilitation. The clinical auxiliary diagnosis value of single biomarker, including small dense low-density lipoprotein concentration (sdLDLc), homocysteine concentration (HCYc) and...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Chunhua, Luo, Yucheng, Ma, Qin, Chen, Chunyan, Xian, Sheng, Gong, Feng, Zhao, Wu, Zeng, Jingjing, Luo, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9724409/
https://www.ncbi.nlm.nih.gov/pubmed/36474148
http://dx.doi.org/10.1186/s12872-022-02969-z
_version_ 1784844408762400768
author Luo, Chunhua
Luo, Yucheng
Ma, Qin
Chen, Chunyan
Xian, Sheng
Gong, Feng
Zhao, Wu
Zeng, Jingjing
Luo, Jun
author_facet Luo, Chunhua
Luo, Yucheng
Ma, Qin
Chen, Chunyan
Xian, Sheng
Gong, Feng
Zhao, Wu
Zeng, Jingjing
Luo, Jun
author_sort Luo, Chunhua
collection PubMed
description BACKGROUND: Timely detection of cerebral infarction is of vital importance in planning intervention effect of rapid rehabilitation. The clinical auxiliary diagnosis value of single biomarker, including small dense low-density lipoprotein concentration (sdLDLc), homocysteine concentration (HCYc) and high-density lipoprotein cholesterol concentration (HDLc) for cerebral infarction has been confirmed by many studies. Whether the use of three biomarkers in combination by calculating (sdLDLc*HCYc)/HDLc ratio could improve the diagnosis ability for primary cerebral infarction remains to be unclear. In the present study, we conducted a cross-sectional study to evaluate the value of (sdLDLc*HCYc)/HDLc ratio in clinical auxiliary diagnosis of primary cerebral infarction. METHODS: A total of 583 participants, including 299 healthy participants as control group and 284 participants diagnosed with first cerebral infarction as experiment group, were included in this respective study. The serum sdLDLc, HDLc and HCYc were measured by peroxidase method, enzyme‐linked immunosorbent assay and an enzymatic method, respectively. RESULTS: The average concentration of sdLDL and HCY (0.69 ± 0.29 mmol/L and 18.14 ± 6.62 μmol/L) in experiment group was significantly higher than those in the control group (0.55 ± 0.22 mmol/L and 10.77 ± 2.67 μmol/L, P < 0.05). However, the average concentration of HDL (1.47 ± 0.25 mmol/L) in the control group was higher than that in the experiment group (1.33 ± 0.28 mmol/L, P < 0.05). Spearman correlation coefficient showed the three indicators are independent of each other. The positive predictive value of (sdLDLc*HCYc)/HDLc ratio (61.27%, 95% CI: 55.31–66.92) is higher than that in single biomarker (sdLDLc: 6.69 95% CI: 4.19–10.42, HCYc: 38.38%, 95% CI: 32.75–44.33, HDLc: 3.87%, 95% CI: 2.05–7.02). Receiver-operating characteristic curve (ROC) analysis illustrated that predictive power of (sdLDLc*HCYc)/HDLc was higher than single biomarker, including sdLDLc, HCYc and HDLc, in primary cerebral infarction. CONCLUSIONS: Therefore, (sdLDLc*HCYc)/HDLc ratio might be a better new indicator in clinical auxiliary diagnosis of primary cerebral infarction, which could be contributed to predicting cerebral infarction occurrence and provide a scientific basis for early prevention.
format Online
Article
Text
id pubmed-9724409
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-97244092022-12-07 Evaluation of (sdLDLc*HCYc)/HDLc ratio in clinical auxiliary diagnosis of primary cerebral infarction Luo, Chunhua Luo, Yucheng Ma, Qin Chen, Chunyan Xian, Sheng Gong, Feng Zhao, Wu Zeng, Jingjing Luo, Jun BMC Cardiovasc Disord Research BACKGROUND: Timely detection of cerebral infarction is of vital importance in planning intervention effect of rapid rehabilitation. The clinical auxiliary diagnosis value of single biomarker, including small dense low-density lipoprotein concentration (sdLDLc), homocysteine concentration (HCYc) and high-density lipoprotein cholesterol concentration (HDLc) for cerebral infarction has been confirmed by many studies. Whether the use of three biomarkers in combination by calculating (sdLDLc*HCYc)/HDLc ratio could improve the diagnosis ability for primary cerebral infarction remains to be unclear. In the present study, we conducted a cross-sectional study to evaluate the value of (sdLDLc*HCYc)/HDLc ratio in clinical auxiliary diagnosis of primary cerebral infarction. METHODS: A total of 583 participants, including 299 healthy participants as control group and 284 participants diagnosed with first cerebral infarction as experiment group, were included in this respective study. The serum sdLDLc, HDLc and HCYc were measured by peroxidase method, enzyme‐linked immunosorbent assay and an enzymatic method, respectively. RESULTS: The average concentration of sdLDL and HCY (0.69 ± 0.29 mmol/L and 18.14 ± 6.62 μmol/L) in experiment group was significantly higher than those in the control group (0.55 ± 0.22 mmol/L and 10.77 ± 2.67 μmol/L, P < 0.05). However, the average concentration of HDL (1.47 ± 0.25 mmol/L) in the control group was higher than that in the experiment group (1.33 ± 0.28 mmol/L, P < 0.05). Spearman correlation coefficient showed the three indicators are independent of each other. The positive predictive value of (sdLDLc*HCYc)/HDLc ratio (61.27%, 95% CI: 55.31–66.92) is higher than that in single biomarker (sdLDLc: 6.69 95% CI: 4.19–10.42, HCYc: 38.38%, 95% CI: 32.75–44.33, HDLc: 3.87%, 95% CI: 2.05–7.02). Receiver-operating characteristic curve (ROC) analysis illustrated that predictive power of (sdLDLc*HCYc)/HDLc was higher than single biomarker, including sdLDLc, HCYc and HDLc, in primary cerebral infarction. CONCLUSIONS: Therefore, (sdLDLc*HCYc)/HDLc ratio might be a better new indicator in clinical auxiliary diagnosis of primary cerebral infarction, which could be contributed to predicting cerebral infarction occurrence and provide a scientific basis for early prevention. BioMed Central 2022-12-06 /pmc/articles/PMC9724409/ /pubmed/36474148 http://dx.doi.org/10.1186/s12872-022-02969-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Luo, Chunhua
Luo, Yucheng
Ma, Qin
Chen, Chunyan
Xian, Sheng
Gong, Feng
Zhao, Wu
Zeng, Jingjing
Luo, Jun
Evaluation of (sdLDLc*HCYc)/HDLc ratio in clinical auxiliary diagnosis of primary cerebral infarction
title Evaluation of (sdLDLc*HCYc)/HDLc ratio in clinical auxiliary diagnosis of primary cerebral infarction
title_full Evaluation of (sdLDLc*HCYc)/HDLc ratio in clinical auxiliary diagnosis of primary cerebral infarction
title_fullStr Evaluation of (sdLDLc*HCYc)/HDLc ratio in clinical auxiliary diagnosis of primary cerebral infarction
title_full_unstemmed Evaluation of (sdLDLc*HCYc)/HDLc ratio in clinical auxiliary diagnosis of primary cerebral infarction
title_short Evaluation of (sdLDLc*HCYc)/HDLc ratio in clinical auxiliary diagnosis of primary cerebral infarction
title_sort evaluation of (sdldlc*hcyc)/hdlc ratio in clinical auxiliary diagnosis of primary cerebral infarction
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9724409/
https://www.ncbi.nlm.nih.gov/pubmed/36474148
http://dx.doi.org/10.1186/s12872-022-02969-z
work_keys_str_mv AT luochunhua evaluationofsdldlchcychdlcratioinclinicalauxiliarydiagnosisofprimarycerebralinfarction
AT luoyucheng evaluationofsdldlchcychdlcratioinclinicalauxiliarydiagnosisofprimarycerebralinfarction
AT maqin evaluationofsdldlchcychdlcratioinclinicalauxiliarydiagnosisofprimarycerebralinfarction
AT chenchunyan evaluationofsdldlchcychdlcratioinclinicalauxiliarydiagnosisofprimarycerebralinfarction
AT xiansheng evaluationofsdldlchcychdlcratioinclinicalauxiliarydiagnosisofprimarycerebralinfarction
AT gongfeng evaluationofsdldlchcychdlcratioinclinicalauxiliarydiagnosisofprimarycerebralinfarction
AT zhaowu evaluationofsdldlchcychdlcratioinclinicalauxiliarydiagnosisofprimarycerebralinfarction
AT zengjingjing evaluationofsdldlchcychdlcratioinclinicalauxiliarydiagnosisofprimarycerebralinfarction
AT luojun evaluationofsdldlchcychdlcratioinclinicalauxiliarydiagnosisofprimarycerebralinfarction